Show simple item record

dc.contributor.authorWade, Rebecca*
dc.contributor.authorSalo-Ahen, Outi*
dc.date.accessioned2021-02-11T20:05:06Z
dc.date.available2021-02-11T20:05:06Z
dc.date.issued2019*
dc.date.submitted2019-04-05 10:34:31*
dc.identifier32831*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/53851
dc.description.abstractThis book is a printed edition of the Special Issue Molecular Modeling in Drug Design that was published in Molecules*
dc.languageEnglish*
dc.subjectQD1-999*
dc.subjectQ1-390*
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PN Chemistryen_US
dc.subject.othermetadynamics*
dc.subject.othernatural compounds*
dc.subject.othervirtual screening*
dc.subject.otherprobe energies*
dc.subject.othermolecular dynamics simulation*
dc.subject.otherhuman ecto-5?-nucleotidase*
dc.subject.otherneural networks*
dc.subject.otherquantitative structure-activity relationship (QSAR)*
dc.subject.otherartificial intelligence*
dc.subject.otherallosterism*
dc.subject.otherin silico screening*
dc.subject.otherdrug discovery*
dc.subject.otheramyloid fibrils*
dc.subject.othermechanical stability*
dc.subject.otheradenosine receptors*
dc.subject.otheradenosine receptor*
dc.subject.otherligand binding*
dc.subject.otherpromiscuous mechanism*
dc.subject.otherAutoGrid*
dc.subject.otherdynamic light scattering*
dc.subject.otherresultant dipole moment*
dc.subject.otherdensity-based clustering*
dc.subject.otherAlzheimer’s disease*
dc.subject.otherdrug design*
dc.subject.otherbiophenols*
dc.subject.otherenzymatic assays*
dc.subject.otherall-atom molecular dynamics simulation*
dc.subject.otherfragment screening*
dc.subject.otheradenosine*
dc.subject.otherdocking*
dc.subject.othermolecular docking*
dc.subject.othercosolvent molecular dynamics*
dc.subject.otherturbidimetry*
dc.subject.othersqualene synthase (SQS)*
dc.subject.othermolecular recognition*
dc.subject.otherprotein-peptide interactions*
dc.subject.otherextracellular loops*
dc.subject.otherFimH*
dc.subject.otherbinding affinity*
dc.subject.otherrational drug design*
dc.subject.otherde novo design*
dc.subject.otherhyperlipidemia*
dc.subject.otherAR ligands*
dc.subject.otheraggregation*
dc.subject.otherproperty prediction*
dc.subject.otherPPI inhibition*
dc.subject.otherdeep learning*
dc.subject.otherproteins*
dc.subject.otherquantitative structure-property prediction (QSPR)*
dc.subject.otherprotein protein interactions*
dc.subject.otherboron cluster*
dc.subject.othertarget-focused pharmacophore modeling*
dc.subject.otherligand–protofiber interactions*
dc.subject.otherstructure-based drug design*
dc.subject.otherscoring function*
dc.subject.othergrid maps*
dc.subject.othersolvent effect*
dc.subject.otheradhesion*
dc.subject.othermolecular dynamics*
dc.subject.otherTraditional Chinese Medicine*
dc.subject.othersteered molecular dynamics*
dc.subject.otherinteraction energy*
dc.subject.otherEphA2-ephrin A1*
dc.subject.othermolecular modeling*
dc.subject.othermethod development*
dc.titleMolecular Modeling in Drug Design*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03897-615-8*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783038976141*
oapen.pages220*
oapen.edition1st*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/